Vertex Pharma scientist talks about the long road to developing non
WASHINGTON (AP) — For decades, patients seeking medication for pain have had two choices: over-the-counter drugs like aspirin or powerful prescription opioids like oxycodone.
Opioid prescriptions have plummeted over the last decade as doctors have become more attuned to the risks of addiction and misuse during the country’s ongoing drug epidemic.
Vertex Pharmaceuticals recently reported positive results for a non-opioid painkiller, one of several medications the Boston-based drugmaker has been developing for various forms of pain. Patients taking the drug after surgery experienced more pain relief than those getting a placebo, although the drug didn’t meet a secondary goal of outperforming treatment with an opioid.
The Associated Press spoke with Vertex’s chief scientist Dr. David Altshuler about the company’s research and development plans. The interview has been edited for length and clarity.
Related articles
'Real life' Martha from Baby Reindeer's million
'Real-life' Baby Reindeer stalker Fiona Harvey today vowed legal action against 'all those who have2024-05-21British POW who was tortured with electric shocks, beaten and starved by Putin's troops in five
A former British soldier who fought alongside Ukrainian troops before being captured and tortured by2024-05-21Thomas Kingston dies aged 45: How the royal family will form a tight circle of support around much
Lady Gabriella Windsor has already felt the immediate support of the wider Royal Family following th2024-05-21LIZ JONES: Kate's strength has made me ashamed. And there's one self
After Kate's bombshell announcement that she is being treated for cancer I read numerous news report2024-05-21I visited the most crowded island on Earth
Likened to a giant armor-plated turtle because the tin roofs are so tightly packed together, Migingo2024-05-21Addicted to hunting lodges, horses and endless parties, the free
She was the last of the big spenders. An overdraft of seven million pounds at Coutts, a taste for ch2024-05-21
atest comment